The molecular basis of Sanfilippo syndrome type B

Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):6101-5. doi: 10.1073/pnas.93.12.6101.

Abstract

The Sanfilippo syndrome type B is a lysosomal storage disorder caused by deficiency of alpha-N-acetylglucosaminidase; it is characterized by profound mental deterioration in childhood and death in the second decade. For understanding the molecular genetics of the disease and for future development of DNA-based therapy, we have cloned the cDNA and gene encoding alpha-N-acetylglucosaminidase. Cloning started with purification of the bovine enzyme and use of a conserved oligonucleotide sequence to probe a human cDNA library. The cDNA sequence was found to encode a protein of 743 amino acids, with a 20- to 23-aa signal peptide immediately preceding the amino terminus of the tissue enzyme and with six potential N-glycosylation sites. The 8.5-kb gene (NAGLU), interrupted by 5 introns, was localized to the 5'-flanking sequence of a known gene, EDH17B, on chromosome 17q21. Five mutations were identified in cells of patients with Sanfilippo syndrome type B: 503del10, R297X, R626X, R643H, and R674H. The occurrence of a frameshift and a nonsense mutation in homozygous form confirms the identity of the NAGLU gene.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetylglucosaminidase / genetics*
  • Amino Acid Sequence
  • Base Sequence
  • Brain / pathology
  • Chromosome Mapping
  • Chromosomes, Human, Pair 17
  • Cloning, Molecular
  • DNA, Complementary
  • Humans
  • Molecular Sequence Data
  • Mucopolysaccharidosis III / genetics*
  • Mucopolysaccharidosis III / pathology
  • Mutation

Substances

  • DNA, Complementary
  • alpha-N-acetyl-D-glucosaminidase
  • Acetylglucosaminidase

Associated data

  • GENBANK/U43572
  • GENBANK/U43573